Private Capital Group, LLC Acorda Therapeutics Inc Transaction History

Private Capital Group, LLC

  • $133 Million
  • Q2 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$0.3 - $1.67 $3 - $16
-10 Closed
0 $0
Q4 2021

Jan 24, 2022
BUY
$2.3 - $4.71 $23 - $47
10 New
10 $0
Q2 2021

Jul 26, 2021
SELL
$3.61 - $5.23 $36 - $52
-10 Closed
0 $0
Q1 2021

Apr 12, 2021
SELL
$3.8 - $8.04 $190 - $401
-50 Reduced 83.33%
10 $0
Q4 2020

Jan 26, 2021
BUY
$3.12 - $6.6 $187 - $396
60 New
60 $0

Others Institutions Holding ACOR

# of Institutions
1
Shares Held
133K
Call Options Held
0
Put Options Held
0
View Full List

About ACORDA THERAPEUTICS INC

ACOR Quotes by TradingView
  • Ticker ACOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 24,338,400
  • Market Cap $6.33M
  • Description
  • Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...
More about ACOR
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email